🇺🇸 FDA

Drug profile · INN

diethylpropion hydrochloride

TENUATE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

diethylpropion hydrochloride (TENUATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN diethylpropion hydrochloride
Brand TENUATE
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12409213

    Live attenuated oral vaccine against shigellosis and typhoid fever

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383566

    Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12102671

    Method of vaccination with an attenuated RSV vaccine formulation

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12054519

    Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11813319

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11801296

    Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11793870

    Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11730801

    Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is diethylpropion hydrochloride?

diethylpropion hydrochloride (TENUATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for diethylpropion hydrochloride?

TENUATE is a marketed brand name for diethylpropion hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of diethylpropion hydrochloride?

diethylpropion hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.